Colombo, F., Aroldi, A., Crippa, S., Cocito, F., Guerra, L., Monaco, L., Granelli, B. M., Mussolin, L., Gambacorti-Passerini, C. (2025). Lorlatinib therapy in relapsed/refractory ALK+ lymphomas previously treated with tyrosine kinase inhibitors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.7054